Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening†

Options in Prophylactic Surgery to Prevent Ovarian Cancer in High-Risk Women: How New Hypotheses of Fallopian Tube Origin Influence Recommendations

(2016) Casey L. Swanson et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles

(2015) Moran Shapira et al.   FERTILITY AND STERILITY

Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

(2015) Timothy R. Rebbeck et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening

(2015) Usha Menon et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction

(2015) B. A. M. Heemskerk-Gerritsen et al.   JNCI-Journal of the National Cancer Institute

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

(2015) Douglas F. Easton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction

(2015) B. A. M. Heemskerk-Gerritsen et al.   JNCI-Journal of the National Cancer Institute

Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels

(2014) R. J. Santen   CLIMACTERIC

The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers

(2014) Arindam Paul   Frontiers in Bioscience-Landmark

Effectiveness of Screening With Annual Magnetic Resonance Imaging and Mammography: Results of the Initial Screen From the Ontario High Risk Breast Screening Program

(2014) Anna M. Chiarelli et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation

(2014) Amy P.M. Finch et al.   JOURNAL OF CLINICAL ONCOLOGY

Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis

(2014) Tara M. Friebel et al.   JNCI-Journal of the National Cancer Institute

Population-based screening for breast and ovarian cancer risk due toBRCA1andBRCA2

(2014) Efrat Gabai-Kapara et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers

(2014) Claudia Marchetti et al.   BMC Womens Health

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis

(2014) K. Metcalfe et al.   BMJ-British Medical Journal

Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

(2013) Kelly-Anne Phillips et al.   JOURNAL OF CLINICAL ONCOLOGY

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer

(2012) Marcia Irene Canto et al.   GUT

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)

(2012) A. Pijpe et al.   BMJ-British Medical Journal

Extended Indications for Nipple-Sparing Mastectomy

(2011) Markus Niemeyer et al.   Breast Journal

Breast cancer after bilateral risk-reducing mastectomy

(2011) A-B Skytte et al.   CLINICAL GENETICS

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

(2011) T. Walsh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk of breast cancer in male BRCA2 carriers

(2010) D. G. R. Evans et al.   JOURNAL OF MEDICAL GENETICS

Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)

(2009) Belinda E. Kiely et al.   BREAST CANCER RESEARCH AND TREATMENT

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

(2009) T. R. Rebbeck et al.   JNCI-Journal of the National Cancer Institute

Prophylactic mastectomy and the timing of breast reconstruction

(2008) M. Morrow et al.   BRITISH JOURNAL OF SURGERY

A Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal CA-125 Screening among Women at Increased Genetic Risk of Ovarian Cancer: Design and Baseline Characteristics: A Gynecologic Oncology Group Study

(2008) M. H. Greene et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Risk reducing mastectomy: outcomes in 10 European centres

(2008) D G R Evans et al.   JOURNAL OF MEDICAL GENETICS

Nipple-sparing mastectomy: Where are we now?

(2008) Alice P. Chung et al.   SURGICAL ONCOLOGY-OXFORD